Neurotrophic factors in serum following ECT: a pilot study

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Neurotrophic factors are crucial for neuronal survival and function.
• Electroconvulsive therapy (ECT) is a treatment for severe affective disorders.
• Previous animal studies suggested ECT increases neurotrophic factors.

Purpose of the Study:

• To investigate changes in serum neurotrophic factors (NGF, BDNF, NT3, NPY), TSH, HGH, and cortisol during ECT treatment in patients with affective disorders.
• To compare human responses to ECT with findings from animal studies.

Main Methods:

• Serum levels of cortisol, TSH, NGF, BDNF, NT3, NPY, and HGH were measured in 15 patients with affective disorders undergoing treatment (antidepressants, psychotherapy, and ECT for 10 patients).
• Clinical assessments including HAM-D scores were performed.
• Statistical analyses were used to evaluate changes and correlations.

Main Results:

• No significant changes were observed in serum levels of NGF, BDNF, NT3, HGH, and TSH.
• Cortisol levels significantly increased during treatment.
• A statistically significant change in NPY levels was noted in only two patients, with uncertain clinical significance.
• Correlations were found between baseline NGF and HAM-D scores, and between end-values of NT3/NPY and HAM-D scores.

Conclusions:

• This pilot study did not replicate animal findings of increased neurotrophic factors with ECT in humans.
• The observed increase in cortisol warrants further investigation.
• Differences may be due to human-animal physiological variations or the small sample size.